Stock Information
Nurix Therapeutics Inc (NRIX)
Ticker Symbol: NRIX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,192.46 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.16
Revenue (TTM): $0.65 M
Dividend Yield: N/A%
ROE: -64.21%
Latest News
-
HC Wainwright & Co. Reiterates Buy on Nurix Therapeutics, Maintains $32 Price Target
Mon, Apr 27, 2026 7:48 AM
Key Financials
Financial data not available